104 related articles for article (PubMed ID: 10689148)
1. Site-directed immune responses in DNA vaccines encoding ligand-antigen fusions.
Lew AM; Brady BJ; Boyle BJ
Vaccine; 2000 Feb; 18(16):1681-5. PubMed ID: 10689148
[TBL] [Abstract][Full Text] [Related]
2. The comparative efficacy of CTLA-4 and L-selectin targeted DNA vaccines in mice and sheep.
Drew DR; Boyle JS; Lew AM; Lightowlers MW; Chaplin PJ; Strugnell RA
Vaccine; 2001 Aug; 19(31):4417-28. PubMed ID: 11483267
[TBL] [Abstract][Full Text] [Related]
3. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction.
Boyle JS; Brady JL; Lew AM
Nature; 1998 Mar; 392(6674):408-11. PubMed ID: 9537327
[TBL] [Abstract][Full Text] [Related]
4. Site-directed immunogenesis.
Langermann S
Nat Med; 1998 May; 4(5):547-8. PubMed ID: 9585219
[No Abstract] [Full Text] [Related]
5. A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge.
Deliyannis G; Boyle JS; Brady JL; Brown LE; Lew AM
Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6676-80. PubMed ID: 10823919
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of gp120-specific immune responses by genetic vaccination with the human immunodeficiency virus type 1 envelope gene fused to the gene coding for soluble CTLA4.
Nayak BP; Sailaja G; Jabbar AM
J Virol; 2003 Oct; 77(20):10850-61. PubMed ID: 14512535
[TBL] [Abstract][Full Text] [Related]
7. Differential requirement for CD80 and CD80/CD86-dependent costimulation in the lung immune response to an influenza virus infection.
Lumsden JM; Roberts JM; Harris NL; Peach RJ; Ronchese F
J Immunol; 2000 Jan; 164(1):79-85. PubMed ID: 10604996
[TBL] [Abstract][Full Text] [Related]
8. Immunoinhibitory DNA vaccine protects against autoimmune diabetes through cDNA encoding a selective CTLA-4 (CD152) ligand.
Prud'homme GJ; Chang Y; Li X
Hum Gene Ther; 2002 Feb; 13(3):395-406. PubMed ID: 11860706
[TBL] [Abstract][Full Text] [Related]
9. A major costimulatory molecule on antigen-presenting cells, CTLA4 ligand A, is distinct from B7.
Wu Y; Guo Y; Liu Y
J Exp Med; 1993 Nov; 178(5):1789-93. PubMed ID: 8228824
[TBL] [Abstract][Full Text] [Related]
10. A mechanistic study of immune system activation by fusion of antigens with the ligand-binding domain of CTLA4.
Chinnasamy D; Tector M; Chinnasamy N; Dennert K; Kozinski KM; Oaks MK
Cancer Immunol Immunother; 2006 Dec; 55(12):1504-14. PubMed ID: 16612600
[TBL] [Abstract][Full Text] [Related]
11. Local gene therapy with CTLA4-immunoglobulin fusion protein in experimental allergic encephalomyelitis.
Croxford JL; O'Neill JK; Ali RR; Browne K; Byrnes AP; Dallman MJ; Wood MJ; Fedlmann M; Baker D
Eur J Immunol; 1998 Dec; 28(12):3904-16. PubMed ID: 9862327
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
Zhou C; Peng G; Jin X; Tang J; Chen Z
Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
[TBL] [Abstract][Full Text] [Related]
13. Immunization with the gene expressing woodchuck hepatitis virus nucleocapsid protein fused to cytotoxic-T-lymphocyte-associated antigen 4 leads to enhanced specific immune responses in mice and woodchucks.
Lu M; Isogawa M; Xu Y; Hilken G
J Virol; 2005 May; 79(10):6368-76. PubMed ID: 15858020
[TBL] [Abstract][Full Text] [Related]
14. Gene gun immunization in a preclinical model is enhanced by B7 targeting.
Tachedjian M; Boyle JS; Lew AM; Horvatic B; Scheerlinck JP; Tennent JM; Andrew ME
Vaccine; 2003 Jun; 21(21-22):2900-5. PubMed ID: 12798633
[TBL] [Abstract][Full Text] [Related]
15. Mounting a targeted strike on unwanted immune responses.
Cohen J
Science; 1992 Aug; 257(5071):751. PubMed ID: 1323142
[No Abstract] [Full Text] [Related]
16. Structure of murine CTLA-4 and its role in modulating T cell responsiveness.
Ostrov DA; Shi W; Schwartz JC; Almo SC; Nathenson SG
Science; 2000 Oct; 290(5492):816-9. PubMed ID: 11052947
[TBL] [Abstract][Full Text] [Related]
17. When ligand becomes receptor--tolerance via B7 signaling on DCs.
Finger EB; Bluestone JA
Nat Immunol; 2002 Nov; 3(11):1056-7. PubMed ID: 12407416
[No Abstract] [Full Text] [Related]
18. B7-CTLA4 interaction enhances both production of antitumor cytotoxic T lymphocytes and resistance to tumor challenge.
Zheng P; Wu Y; Guo Y; Lee C; Liu Y
Proc Natl Acad Sci U S A; 1998 May; 95(11):6284-9. PubMed ID: 9600957
[TBL] [Abstract][Full Text] [Related]
19. The effect of antigen size on the immunogenicity of antigen presenting cell targeted DNA vaccine.
Jia R; Guo JH; Fan MW
Int Immunopharmacol; 2012 Jan; 12(1):21-5. PubMed ID: 21945335
[TBL] [Abstract][Full Text] [Related]
20. Transduction of dendritic cells with adenoviral vectors encoding CTLA4-Ig markedly reduces their allostimulatory activity.
Lu L; Lee WC; Gambotto A; Zhong C; Robbins PD; Qian S; Fung JJ; Thomson AW
Transplant Proc; 1999; 31(1-2):797. PubMed ID: 10083343
[No Abstract] [Full Text] [Related]
[Next] [New Search]
